Related Experiment Video
Updated: Oct 29, 2025

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
Assessment of galactose-1-phosphate uridyltransferase activity in cells and tissues
Megan L Brophy1, John E Murphy1, Robert D Bell1
1Rare Disease Research Unit, Worldwide Research, Development and Medicine, Pfizer, Inc. Cambridge, MA 02139, USA.
Abstract:
Galactosemias are a family of autosomal recessive genetic disorders resulting from impaired enzymes of the Leloir pathway of galactose metabolism including galactokinase, galactose uridyltransferase, and UDP-galactose 4-epimerase that are critical for conversion of galactose into glucose-6-phosphate. To better understand pathophysiological mechanisms involved in galactosemia and develop novel therapies to address the unmet need in patients, it is important to develop reliable assays to measure the activity of the Leloir pathway enzymes. Here we describe in-depth methods for indirectly measuring galacose-1-phosphate uridyltransferase activity in cell culture and animal tissues.

